This company has been marked as potentially delisted and may not be actively trading. Deep Medicine Acquisition (DMAQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DMAQ vs. IMTE, AQB, SPGC, YMAT, SONY, GOLF, YETI, PTON, KN, and ARLOShould you be buying Deep Medicine Acquisition stock or one of its competitors? The main competitors of Deep Medicine Acquisition include Integrated Media Technology (IMTE), AquaBounty Technologies (AQB), Sacks Parente Golf (SPGC), J-Star (YMAT), Sony Group (SONY), Acushnet (GOLF), YETI (YETI), Peloton Interactive (PTON), Knowles (KN), and Arlo Technologies (ARLO). These companies are all part of the "recreation" industry. Deep Medicine Acquisition vs. Integrated Media Technology AquaBounty Technologies Sacks Parente Golf J-Star Sony Group Acushnet YETI Peloton Interactive Knowles Arlo Technologies Integrated Media Technology (NASDAQ:IMTE) and Deep Medicine Acquisition (NASDAQ:DMAQ) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, analyst recommendations, earnings and institutional ownership. Which has more risk and volatility, IMTE or DMAQ? Integrated Media Technology has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Comparatively, Deep Medicine Acquisition has a beta of 0.02, suggesting that its stock price is 98% less volatile than the S&P 500. Does the media refer more to IMTE or DMAQ? In the previous week, Integrated Media Technology's average media sentiment score of 0.00 equaled Deep Medicine Acquisition'saverage media sentiment score. Company Overall Sentiment Integrated Media Technology Neutral Deep Medicine Acquisition Neutral Is IMTE or DMAQ more profitable? Company Net Margins Return on Equity Return on Assets Integrated Media TechnologyN/A N/A N/A Deep Medicine Acquisition N/A N/A N/A Do insiders & institutionals believe in IMTE or DMAQ? 18.4% of Deep Medicine Acquisition shares are held by institutional investors. 2.1% of Integrated Media Technology shares are held by company insiders. Comparatively, 1.7% of Deep Medicine Acquisition shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the MarketBeat Community believe in IMTE or DMAQ? Integrated Media Technology and Deep Medicine Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformIntegrated Media TechnologyN/AN/ADeep Medicine AcquisitionN/AN/A Which has preferable valuation & earnings, IMTE or DMAQ? Deep Medicine Acquisition has lower revenue, but higher earnings than Integrated Media Technology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntegrated Media Technology$113.20K37.43-$16.73MN/AN/ADeep Medicine AcquisitionN/AN/AN/AN/AN/A SummaryIntegrated Media Technology beats Deep Medicine Acquisition on 3 of the 4 factors compared between the two stocks. Get Deep Medicine Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DMAQ vs. The Competition Export to ExcelMetricDeep Medicine AcquisitionHolding Offices Industry SectorNASDAQ ExchangeMarket Cap$889,000.00$478.12M$2.53B$8.42BDividend YieldN/A7.55%13.04%4.10%P/E RatioN/A2.5311.3419.69Price / SalesN/A73.263,565,749.89118.34Price / CashN/A69.0159.5734.62Price / BookN/A7.023.544.50Net IncomeN/A$35.22M-$428.08M$248.32M Deep Medicine Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DMAQDeep Medicine AcquisitionN/A$0.20-5.1%N/A-83.3%$889,000.00N/A0.0093High Trading VolumeIMTEIntegrated Media TechnologyN/A$1.19-5.2%N/A-41.1%$4.07M$113,200.000.0010Gap DownAQBAquaBounty Technologies0.7486 of 5 stars$0.79-0.6%N/A-52.8%$3.04M$1.26M-0.04100Positive NewsEarnings ReportGap DownSPGCSacks Parente GolfN/AN/AN/AN/A$180,000.00$2.49M-0.0318Gap DownHigh Trading VolumeYMATJ-StarN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeSONYSony Group2.6906 of 5 stars$24.93+0.2%$28.00+12.3%+659.5%$150.68B$13.81T20.22108,900Positive NewsAnalyst DowngradeGOLFAcushnet3.2463 of 5 stars$71.12+1.3%$70.00-1.6%+9.5%$4.17B$2.45B24.117,300Positive NewsYETIYETI3.9354 of 5 stars$32.09+2.3%$39.40+22.8%-25.8%$2.66B$1.84B15.59920Gap UpPTONPeloton Interactive3.7708 of 5 stars$6.47-2.3%$8.30+28.4%+97.6%$2.52B$2.53B-8.399,770Insider TradeGap UpKNKnowles1.3464 of 5 stars$17.16+0.9%$19.33+12.7%-5.3%$1.49B$552.40M-6.477,000Trending NewsARLOArlo Technologies2.5989 of 5 stars$13.55-1.4%$20.25+49.5%+11.5%$1.40B$505.75M-54.16350Gap Up Related Companies and Tools Related Companies Integrated Media Technology Alternatives AquaBounty Technologies Alternatives Sacks Parente Golf Alternatives J-Star Alternatives Sony Group Alternatives Acushnet Alternatives YETI Alternatives Peloton Interactive Alternatives Knowles Alternatives Arlo Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DMAQ) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Deep Medicine Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Deep Medicine Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DMAQ Stock Free DMAQ Stock Alerts